JULIE REAVILL, PA-C
Medical Physician Assistant in DANVILLE, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JULIE REAVILL, PA-C filed 3,741 Medicare Part D claims in 2023 as a Medical Physician Assistant in DANVILLE, Illinois, prescribing 84% generic.
- 4K
- Part D claims, 2023
- 84%
- generic prescribing
- $298.22
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JULIE REAVILL, PA-C's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
3,741 Top 9% higher than 91% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about JULIE REAVILL, PA-C?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Illinois
How Medical Physician Assistant compares to other specialties among Illinois providers
Medical Physician Assistant share within Illinois
Medical Physician Assistant is one of the more visible NUCC categories in Illinois
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Medical Physician Assistant (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Medical Physician Assistant ABMS/AOA estimate
Est. board-certified rate (Medical Physician Assistant) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Medical Physician Assistant US NPIs
Specialty board-certified rate — Medical Physician Assistant estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JULIE REAVILL, PA-C appears in the CMS NPPES registry as a Medical Physician Assistant provider holding PA-C credentials at 1808 N VERMILION ST, DANVILLE, IL, 61832, with a listed phone of (217) 597-9393. NPI 1114197241 was issued on 03/04/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what REAVILL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,741 prescription claims written by this provider, covering 213 Medicare beneficiaries and totaling roughly $456K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 1.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Medical Physician Assistant is a mid-sized specialty nationwide, with 40,527 enrolled providers across 55 states and an average of 1,077 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1114197241 |
|---|---|
| Specialty | Medical Physician Assistant |
| Credentials | PA-C |
| Gender | Female |
| NPI Issued | 03/04/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JULIE REAVILL, PA-C's current license status, disciplinary history, and board certifications with the Illinois Department of Financial and Professional Regulation in Illinois before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JULIE REAVILL, PA-C. Source: openpaymentsdata.cms.gov.
Total received
$298
Largest payer
Teva Pharmaceuticals USA, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Illinois IDFPR 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to JULIE REAVILL, PA-C. To verify JULIE REAVILL, PA-C's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 3,741 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,896
- Total Day Supply
- 170,219
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $410K
- Generic Drug Cost
- $42K
- Opioid Claims
- 53 (1.4% rate)
- Antibiotic Claims
- 61
Patient Demographics
- Average Patient Age
- 61.7 years
- Avg HCC Risk Score
- 1.13
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 94, 65-74: 97, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JULIE REAVILL, PA-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
271 claims
- Metformin Hcl
Metformin Hcl
191 claims
- Lisinopril
Lisinopril
169 claims
- Gabapentin
Gabapentin
140 claims
- Levothyroxine Sodium
Levothyroxine Sodium
134 claims
- Amlodipine Besylate
Amlodipine Besylate
131 claims
- Montelukast Sodium
Montelukast Sodium
119 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
117 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 271 |
| Metformin Hcl | 191 |
| Lisinopril | 169 |
| Gabapentin | 140 |
| Levothyroxine Sodium | 134 |
| Amlodipine Besylate | 131 |
| Montelukast Sodium | 119 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 117 |
| Hydrochlorothiazide | 112 |
| Trulicity Dulaglutide | 111 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Physician Assistant Overview
How JULIE REAVILL, PA-C fits within the Medical Physician Assistant landscape nationally.
JULIE REAVILL, PA-C's 3,741 claims are above the specialty average of 1,077.
Nearby Medical Physician Assistant Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as REAVILL.
Compare Medical Physician Assistant nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Illinois
Frequently Asked Questions
What is JULIE REAVILL, PA-C's specialty? ▼
How much does JULIE REAVILL, PA-C prescribe under Medicare Part D? ▼
Where is JULIE REAVILL, PA-C located? ▼
What is JULIE REAVILL, PA-C's NPI number? ▼
Does JULIE REAVILL, PA-C prescribe more brand-name or generic drugs? ▼
Does JULIE REAVILL, PA-C prescribe opioids? ▼
How many Medical Physician Assistant providers are there in the US? ▼
What drugs does JULIE REAVILL, PA-C prescribe most often? ▼
Does JULIE REAVILL, PA-C accept Medicare? ▼
How can I verify JULIE REAVILL, PA-C's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology